Kathryn M Kienle

Title: Kathryn M Kienle: Innovator in Pharmaceutical Composition

Introduction

Kathryn M Kienle is a notable inventor based in Kalamazoo, MI (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating medical conditions.

Latest Patents

Kienle holds a patent for an oral liquid tolterodine composition. This pharmaceutical composition is designed as an orally deliverable liquid that includes water with a pharmaceutically acceptable water-soluble salt of a tolterodine related compound. The composition is formulated at a therapeutically effective concentration and has a pH ranging from about 2 to about 6. Additionally, it contains a sweetening agent and an antimicrobial agent that is effective at the specified pH. This innovative composition is particularly useful for treating muscarinic receptor mediated disorders, such as overactive bladder, by administering a therapeutically effective amount to the subject.

Career Highlights

Kienle is associated with Pharmacia & Upjohn Company, where she has been able to apply her expertise in pharmaceutical development. Her work has contributed to advancements in treatments for various medical conditions.

Collaborations

Some of her notable coworkers include Joseph Peter Reo and Jennifer K Fredrickson. Their collaborative efforts have likely enhanced the research and development processes within their projects.

Conclusion

Kathryn M Kienle's contributions to pharmaceutical compositions demonstrate her innovative spirit and dedication to improving medical treatments. Her work continues to impact the field positively.